Traci N Adams1, Chad A Newton2, Kiran Batra3, Muhanned Abu-Hijleh2, Tyonn Barbera2, Jose Torrealba4, Craig S Glazer2. 1. Division of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX, 75219, USA. traci.adams@utsouthwestern.edu. 2. Division of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX, 75219, USA. 3. Department of Radiology, University of Texas Southwestern Medical Center, Dallas, TX, USA. 4. Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Abstract
INTRODUCTION: Making the diagnosis of HP is challenging due to a lack of consensus criteria and variability of both pathologic and radiographic findings. The purpose of this retrospective study was to determine the diagnostic utility of the combination of BAL lymphocyte count and TBBX in patients with HP. METHODS: We conducted a retrospective cohort study of all patients with a MDD diagnosis of HP at a single center. RESULTS: 155 patients were included in the study. 49% of patients who underwent BAL had a lymphocyte count > 20, 42% had a lymphocyte count > 30, and 34% had lymphocyte count > 40%. The median BAL lymphocyte count was higher in inflammatory HP compared to fibrotic HP. The addition of TBBX to BAL significantly increased the diagnostic yield regardless of the BAL lymphocyte cutoff used. The yield of bronchoscopy with TBBX and BAL when a lymphocyte count > 40% was used as a cutoff was 52%. CONCLUSIONS: Our study suggests that the combination of TBBX with BAL significantly increases the likelihood that the procedure will provide adequate additional information to allow a confident MDD diagnosis of HP and may reduce the need for SLB in the diagnostic workup of HP.
INTRODUCTION: Making the diagnosis of HP is challenging due to a lack of consensus criteria and variability of both pathologic and radiographic findings. The purpose of this retrospective study was to determine the diagnostic utility of the combination of BAL lymphocyte count and TBBX in patients with HP. METHODS: We conducted a retrospective cohort study of all patients with a MDD diagnosis of HP at a single center. RESULTS: 155 patients were included in the study. 49% of patients who underwent BAL had a lymphocyte count > 20, 42% had a lymphocyte count > 30, and 34% had lymphocyte count > 40%. The median BAL lymphocyte count was higher in inflammatory HP compared to fibrotic HP. The addition of TBBX to BAL significantly increased the diagnostic yield regardless of the BAL lymphocyte cutoff used. The yield of bronchoscopy with TBBX and BAL when a lymphocyte count > 40% was used as a cutoff was 52%. CONCLUSIONS: Our study suggests that the combination of TBBX with BAL significantly increases the likelihood that the procedure will provide adequate additional information to allow a confident MDD diagnosis of HP and may reduce the need for SLB in the diagnostic workup of HP.
Authors: Evans R Fernández Pérez; Jeffrey J Swigris; Anna V Forssén; Olga Tourin; Joshua J Solomon; Tristan J Huie; Amy L Olson; Kevin K Brown Journal: Chest Date: 2013-11 Impact factor: 9.410
Authors: Margaret L Salisbury; Jeffrey L Myers; Elizabeth A Belloli; Ella A Kazerooni; Fernando J Martinez; Kevin R Flaherty Journal: Am J Respir Crit Care Med Date: 2017-09-15 Impact factor: 21.405
Authors: Jamie S Sheth; John A Belperio; Michael C Fishbein; Ella A Kazerooni; Amir Lagstein; Susan Murray; Jeff L Myers; Richard H Simon; Thomas H Sisson; Baskaran Sundaram; Eric S White; Meng Xia; David Zisman; Kevin R Flaherty Journal: Chest Date: 2016-10-08 Impact factor: 9.410
Authors: Helen E Jo; Ian N Glaspole; Kovi C Levin; Samuel R McCormack; Annabelle M Mahar; Wendy A Cooper; Rhoda Cameron; Samantha J Ellis; Alice M Cottee; Susanne E Webster; Lauren K Troy; Paul J Torzillo; Peter Corte; Karen M Symons; Nicole Taylor; Tamera J Corte Journal: Respirology Date: 2016-07-18 Impact factor: 6.424
Authors: Andre B Botelho; Rimarcs G Ferreira; Ester N A M Coletta; Milena T Cerezoli; Rafaela B Martins; Paula S Gomes; A Gimenez; Luiz H Ota; Maria Raquel Soares; Carlos Alberto C Pereira Journal: Sarcoidosis Vasc Diffuse Lung Dis Date: 2021-06-28 Impact factor: 0.670
Authors: Ganesh Raghu; Martine Remy-Jardin; Christopher J Ryerson; Jeffrey L Myers; Michael Kreuter; Martina Vasakova; Elena Bargagli; Jonathan H Chung; Bridget F Collins; Elisabeth Bendstrup; Hassan A Chami; Abigail T Chua; Tamera J Corte; Jean-Charles Dalphin; Sonye K Danoff; Javier Diaz-Mendoza; Abhijit Duggal; Ryoko Egashira; Thomas Ewing; Mridu Gulati; Yoshikazu Inoue; Alex R Jenkins; Kerri A Johannson; Takeshi Johkoh; Maximiliano Tamae-Kakazu; Masanori Kitaichi; Shandra L Knight; Dirk Koschel; David J Lederer; Yolanda Mageto; Lisa A Maier; Carlos Matiz; Ferran Morell; Andrew G Nicholson; Setu Patolia; Carlos A Pereira; Elisabetta A Renzoni; Margaret L Salisbury; Moises Selman; Simon L F Walsh; Wim A Wuyts; Kevin C Wilson Journal: Am J Respir Crit Care Med Date: 2020-08-01 Impact factor: 30.528